To study the ability of AMP-DNM to also correct hepatic manifestations of the metabolic syndrome, LDLR(−/−) mice were kept on a western-type diet for 12 weeks to induce NASH. Here, LDLR is linked to metabolic dysfunction-associated steatohepatitis.